By Katherine Hamilton
Merit Medical Systems shares rose after the company said it expects sales to come in ahead of Wall Street expectations and it chose a new chief executive to replace its founder and long-time head.
The stock advanced 5% to $95.52 in after-hours trading on Monday.
The South Jordan, Utah, company gave a preliminary revenue estimate of $380 million to $384 million for the second quarter. That would be ahead of the $372.5 million analysts are forecasting, according to FactSet.
That comes after Merit in April cut its full-year adjusted earnings outlook due to the projected affect of tariffs.
Merit also named Martha Aronson as chief executive and president. She will succeed Fred Lampropoulos, who founded the company in 1987 and has been chief executive since then.
The transition is scheduled for Oct. 3. Lampropoulos will serve as chairman after that.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
July 07, 2025 17:52 ET (21:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.